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Objective. SSI rates after gynecologic oncology surgery vary from 5% to 35%, but are up to 45% in patients with 31 diabetes mellitus (DM). Strict postoperative glucose control by insulin infusion has been shown to lower morbidity, 32 but not specifically SSI rates. Our project studied continuous postoperative insulin infusion for 24 h for gynecologic 33 oncology patients with DM and hyperglycemia with a target blood glucose of b 139 mL/dL and a primary outcome 34 of the protocol's impact on SSI rates. 35 Methods. We compared SSI rates retrospectively among three groups. Group 1 was composed of patients with 36 DM whose blood glucose was controlled with intermittent subcutaneous insulin injections Q7 . Group 2 was composed 37 of patients with DM and postoperative hyperglycemia whose blood glucose was controlled by insulin infusion Q8 . 38 Group 3 was composed of patients with neither DM nor hyperglycemia. We controlled for all relevant factors asso-39 ciated with SSI Q9 . 40 Results. We studied a total of 372 patients. Patients in Group 2 had an SSI rate of 26/135 (19%), similar to patients 41 in Group 3 whose rate was 19/89 (21%). Both were significantly lower than the SSI rate (43/148, 29%) of patients 42 in Group 1. This reduction of 35% is significant (p = 0.02). Multivariate analysis showed an odd ratio = 0.5 43 (0.28-0.91) in reducing SSI rates after instituting this protocol. 44 
Conclusions. Initiating intensive glycemic control for 24 h after gynecologic oncology surgery in patients with

Introduction
53
Surgical site infection (SSI), a surgical complication, is defined as 54 infection(s) occurring after surgical procedures. It is the third most 55 common (17%) [1] of all nosocomial infections in hospitalized patients,
56
and is a significant cause of postoperative morbidity, mortality, and groups by blood glucose control methods after controlling for covariates.
175
Results were quantified in terms of odds ratios (ORs) with corresponding 176 95% confidence intervals (CIs). All statistical analyses were performed 177 using SAS 9.1 software (SAS Institute Inc. Cary, NC). Statistical significance 178 was defined as a two-tailed p-value b 0.05. This represents a 50% reduction in the odds of having SSI in diabetic 215 patients after implementing the insulin infusion, bringing the incidence 216 to the same level as that of the non-diabetic patients in Group 3.
217
As seen in Fig. 3 only is DM an independent risk factor for developing SSI, but a higher 256 postoperative blood glucose (N250 mg/dL) was associated with a 257 higher SSI rate (3.7%) compared to a rate of 0.6% in patients with a 258 blood glucose b150 mg/dL [19] . McConnell et al. reported that in colo-259 rectal surgery, the SSI rate dropped from 29% to 14% in favor of better 260 postoperative blood glucose control [18] . Similarly, in hepato-biliary 261 surgery, the rate of SSI was 20% when the average postoperative blood 262 glucose was b200 mg/dL compared to 52% for patients when it was 263 N200 mg/dL (p b 0.01) [13] . The aforementioned studies underscore Another recent Cochrane analysis [20] did not find any significant differ- a Statistically different from the other two groups. Fig. 3 . SSI rate in each group. The odds of having SSI in the sliding group (Group 1) was about two times higher than the 
study that had a specific patient population, postoperative blood glucose 289 target and modality, and outcome. showed significantly lower hypoglycemia rates after adopting the con- protocol.
325
The strengths of our study include having a large number of patients where the goal of glycemic control was generally less than 200 mg/dL.
334
Our study looked at surgical site infection as a primary outcome, as well.
335
Lastly, we implemented a multivariate analysis that allowed us to control 336 for many obvious clinical factors that affect SSI.
337
The major limitations of our study include those typically associated 
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